OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects
Sign Up to like & getrecommendations! Published in 2022 at "Behavioural Pharmacology"
DOI: 10.1097/fbp.0000000000000684
Abstract: Drugs targeting mu opioid receptors are the mainstay of clinical practice for treating moderate-to-severe pain. While they can offer excellent analgesia, their use can be limited by adverse effects, including constipation, respiratory depression, tolerance, and… read more here.
Keywords: orex 1038; adverse effects; pain; limited adverse ... See more keywords